RHOA and ovarian carcinoma: Both RhoA and Wnt-5a mRNA and protein expression were positively associated with International Federation of Gynecology and Obstetrics (FIGO) stage (III/IV vs. I/II; Figure 1E,L, p < 0.05) and degree of differentiation in ovarian carcinoma (poorly differentiated carcinomas vs. other subtypes; Figure 1F,M, p < 0.05).